摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5,7-二硝基-3-苯基-2-氯喹喔啉 | 1010857-57-4

中文名称
5,7-二硝基-3-苯基-2-氯喹喔啉
中文别名
——
英文名称
5,7-dinitro-3-phenyl-2-chloroquinoxaline
英文别名
2-Chloro-5,7-dinitro-3-phenylquinoxaline
5,7-二硝基-3-苯基-2-氯喹喔啉化学式
CAS
1010857-57-4
化学式
C14H7ClN4O4
mdl
——
分子量
330.687
InChiKey
VJAFBWDNHMPUSE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.5
  • 重原子数:
    23
  • 可旋转键数:
    1
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    117
  • 氢给体数:
    0
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2
    • 3

反应信息

  • 作为反应物:
    描述:
    3,4,5-三甲氧基苄胺5,7-二硝基-3-苯基-2-氯喹喔啉丙醇 为溶剂, 反应 1.0h, 以95%的产率得到5,7-dinitro-3-phenyl-2-[(3,4,5-trimethoxybenzyl)amino]quinoxaline
    参考文献:
    名称:
    Synthesis and in vitro antitumor activity of new quinoxaline derivatives
    摘要:
    A series of novel 5,7-diamino-3-phenyl-2-benzylamino, 2-phenoxy, and 2-thiophenyl substituted quinoxalines has been designed, synthesized and evaluated for their in vitro antitumor activity towards cell lines of nine different types of human cancers. Some of these compounds exhibited inhibitory effects on the growth of a wide range of cancer cell lines generally at 10(-6) M, in some cases at 10(-7) M and 10(-8) M concentrations. Within this series the benzylamino quinoxaline derivatives 1b-7b were the most active, whereas compound 2c showed the highest MG_MD value (-5.66). (C) 2008 Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2008.07.025
  • 作为产物:
    描述:
    5,7-dinitro-3-phenylquinoxalin-2(1H)one氯化亚砜N,N-二甲基甲酰胺 作用下, 反应 1.67h, 以90%的产率得到5,7-二硝基-3-苯基-2-氯喹喔啉
    参考文献:
    名称:
    Synthesis of N-(5,7-diamino-3-phenyl-quinoxalin-2-yl)-3,4,5-substituted anilines and N-[4[(5,7-diamino-3-phenylquinoxalin-2-yl)amino]benzoyl]-l-glutamic acid diethyl ester: Evaluation of in vitro anti-cancer and anti-folate activities
    摘要:
    Several diamino quinoxalines were designed, synthesized and evaluated as anti-tumor agents. Two compounds showed the most potent cytotoxic activities against the leukemia CCRF-CEM cell line (GI(50) < 0-01 mu M) and the ovarian cancer cell line OVCAR-4 (GI(50) = 0.03 mu M), respectively, with comparable/better activities than Methotrexate (MTX). Docking calculations of the complexes of hDHFR with the most active compounds identified the binding mode of the described molecules with respect to MTX. (C) 2007 Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2007.03.035
点击查看最新优质反应信息

文献信息

  • Synthesis and in vitro antitumor activity of new quinoxaline derivatives
    作者:Paola Corona、Antonio Carta、Mario Loriga、Gabriella Vitale、Giuseppe Paglietti
    DOI:10.1016/j.ejmech.2008.07.025
    日期:2009.4
    A series of novel 5,7-diamino-3-phenyl-2-benzylamino, 2-phenoxy, and 2-thiophenyl substituted quinoxalines has been designed, synthesized and evaluated for their in vitro antitumor activity towards cell lines of nine different types of human cancers. Some of these compounds exhibited inhibitory effects on the growth of a wide range of cancer cell lines generally at 10(-6) M, in some cases at 10(-7) M and 10(-8) M concentrations. Within this series the benzylamino quinoxaline derivatives 1b-7b were the most active, whereas compound 2c showed the highest MG_MD value (-5.66). (C) 2008 Elsevier Masson SAS. All rights reserved.
  • Synthesis of N-(5,7-diamino-3-phenyl-quinoxalin-2-yl)-3,4,5-substituted anilines and N-[4[(5,7-diamino-3-phenylquinoxalin-2-yl)amino]benzoyl]-l-glutamic acid diethyl ester: Evaluation of in vitro anti-cancer and anti-folate activities
    作者:Paola Corona、Mario Loriga、M. Paola Costi、Stefania Ferrari、Giuseppe Paglietti
    DOI:10.1016/j.ejmech.2007.03.035
    日期:2008.1
    Several diamino quinoxalines were designed, synthesized and evaluated as anti-tumor agents. Two compounds showed the most potent cytotoxic activities against the leukemia CCRF-CEM cell line (GI(50) < 0-01 mu M) and the ovarian cancer cell line OVCAR-4 (GI(50) = 0.03 mu M), respectively, with comparable/better activities than Methotrexate (MTX). Docking calculations of the complexes of hDHFR with the most active compounds identified the binding mode of the described molecules with respect to MTX. (C) 2007 Elsevier Masson SAS. All rights reserved.
查看更多